{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:29:37Z","timestamp":1760956177647,"version":"3.41.2"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Non-infectious chronic diseases, especially inflammatory bowel diseases (IBDs), hypertension, and diabetes mellitus, are characterized by a prolonged and multisystemic course, and their incidence increases annually, usually causing serious economic burden and psychological stress for patients. Therefore, these diseases deserve scientific and consistent disease management. In addition, the lack of a comprehensive \u201cearly disease clues tracking\u2014personalized treatment system\u2014follow-up\u201d model in hospitals also exacerbates this dilemma. Based on these facts, we propose an individualized prediction management system for IBDs based on chronic diseases, focusing on the established IBDs-related prediction models and summarizing their advantages and disadvantages. We call on researchers to pay attention to the integration of models with clinical practice and the continuous correction of models to achieve truly individualized medical treatment for chronic diseases, thus providing substantial value for the rapid diagnosis and adequate treatment of chronic diseases such as IBDs, which follow the \u201crelapse-remission\u201d disease model, and realizing long-term drug use and precise disease management for patients. The goal is to achieve a new level of chronic disease management by scientifically improving long-term medication, precise disease management, and individualized medical treatment, effectively prolonging the remission period and reducing morbidity and disability rates.<\/jats:p>","DOI":"10.3389\/fmed.2023.1186143","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T21:27:13Z","timestamp":1683754033000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["New pattern of individualized management of chronic diseases: focusing on inflammatory bowel diseases and looking to the future"],"prefix":"10.3389","volume":"10","author":[{"given":"Xi","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zining","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiexin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danni","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhujun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoxia","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoguo","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1001\/jama.2022.15436","article-title":"Chronic disease burden and financial problems are intertwined","volume":"328","author":"Slomski","year":"2022","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1093\/ecco-jcc\/jjab029","article-title":"The burden of inflammatory bowel disease in Europe in 2020[J]","volume":"15","author":"Zhao","year":"2021","journal-title":"J Crohns Colitis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S0140-6736(14)61347-7","article-title":"The burden of disease in older people and implications for health policy and practice","volume":"385","author":"Prince","year":"2015","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.1038\/s41598-022-09784-8","article-title":"Elements of chronic disease management service system: an empirical study from large hospitals in China","volume":"12","author":"Zhao","year":"2022","journal-title":"Sci Rep"},{"volume-title":"And Related Disorders","year":"2017","author":"Cardiovascular","key":"ref6"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(18)30323-4","article-title":"Action to address the household economic burden of non-communicable diseases","volume":"391","author":"Jan","year":"2018","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/jgh.14872","article-title":"The epidemiology of inflammatory bowel disease: east meets west","volume":"35","author":"Mak","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nri2340","article-title":"The genetics and immunopathogenesis of inflammatory bowel disease","volume":"8","author":"Cho","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/j.gastro.2020.03.007","article-title":"Serum biomarkers identify patients who will develop inflammatory bowel diseases up to 5 years before diagnosis","volume":"159","author":"Torres","year":"2020","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1053\/j.gastro.2020.08.017","article-title":"Transcription and DNA methylation patterns of blood-derived CD8(+) T cells are associated with age and inflammatory bowel disease but do not predict prognosis","volume":"160","author":"Gasparetto","year":"2021","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41575-022-00634-6","article-title":"Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment","volume":"19","author":"Bisgaard","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1056\/NEJMra1907607","article-title":"Newer biologic and small-molecule therapies for inflammatory bowel disease","volume":"385","author":"Baumgart","year":"2021","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/ajg.2010.343","article-title":"Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort","volume":"106","author":"Vavricka","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s12016-017-8617-4","article-title":"Skin manifestations of inflammatory bowel disease","volume":"53","author":"Greuter","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1026629528233","article-title":"Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis","volume":"44","author":"Das","year":"1999","journal-title":"Dig Dis Sci"},{"key":"ref19","first-page":"711","article-title":"Extracolonic diagnoses in ulcerative colitis: an epidemiological study","volume":"85","author":"Mons\u00e9n","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00384-007-0275-1","article-title":"The prevalence of ocular involvement in patients with inflammatory bowel disease","volume":"22","author":"Yilmaz","year":"2007","journal-title":"Int J Color Dis"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/bjo.85.2.219","article-title":"Prevalence of subclinical anterior uveitis in adult patients with inflammatory bowel disease","volume":"85","author":"Verbraak","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/0016-5085(79)90391-3","article-title":"National Cooperative Crohn's disease study: extraintestinal manifestations and perianal complications","volume":"77","author":"Rankin","year":"1979","journal-title":"Gastroenterology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.3748\/wjg.v9.i10.2300","article-title":"Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study","volume":"9","author":"Lakatos","year":"2003","journal-title":"World J Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00054725-200405000-00005","article-title":"Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study","volume":"10","author":"Ricart","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/ecco-jcc\/jjab155","article-title":"Machine learning-based prediction models for diagnosis and prognosis in inflammatory bowel diseases: a systematic review","volume":"16","author":"Nguyen","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/ng.3947","article-title":"A functional genomics predictive network model identifies regulators of inflammatory bowel disease","volume":"49","author":"Peters","year":"2017","journal-title":"Nat Genet"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"c3369","DOI":"10.1136\/bmj.c3369","article-title":"Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis","volume":"341","author":"van Rheenen","year":"2010","journal-title":"BMJ"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat Microbiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.2147\/JIR.S306816","article-title":"Application of artificial intelligence modeling technology based on multi-omics in noninvasive diagnosis of inflammatory bowel disease","volume":"14","author":"Huang","year":"2021","journal-title":"J Inflamm Res"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1053\/j.gastro.2022.12.007","article-title":"AGA clinical practice guideline on the role of biomarkers for the management of ulcerative colitis","volume":"164","author":"Singh","year":"2023","journal-title":"Gastroenterology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e167109","DOI":"10.1371\/journal.pone.0167109","article-title":"Exploration of serum proteomic profiling and diagnostic model that differentiate Crohn's disease and intestinal tuberculosis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nicl.2014.08.023","article-title":"Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness","volume":"6","author":"Lebedev","year":"2014","journal-title":"Neuroimage Clin"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12920-019-0540-5","article-title":"Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia","volume":"12","author":"Shi","year":"2019","journal-title":"BMC Med Genet"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"105458","DOI":"10.1016\/j.compbiomed.2022.105458","article-title":"Machine learning in medical applications: a review of state-of-the-art methods","volume":"145","author":"Shehab","year":"2022","journal-title":"Comput Biol Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.ajog.2005.09.002","article-title":"Methods of clinical prediction","volume":"194","author":"Grobman","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"20471","DOI":"10.18632\/aging.103861","article-title":"Development of a susceptibility gene based novel predictive model for the diagnosis of ulcerative colitis using random forest and artificial neural network","volume":"12","author":"Li","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00535-018-1479-6","article-title":"The state of the art on treatment of Crohn's disease","volume":"53","author":"Shi","year":"2018","journal-title":"J Gastroenterol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0016-5107(04)01878-4","article-title":"Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD","volume":"60","author":"Daperno","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"323009357","DOI":"10.1177\/1756284818769075","article-title":"Monitoring Crohn's disease activity: endoscopy, fecal markers and computed tomography enterography","volume":"11","author":"Lopes","year":"2018","journal-title":"Ther Adv Gastroenterol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.gie.2017.03.012","article-title":"Development and reliability of the new endoscopic virtual chromoendoscopy score: the PICaSSO (Paddington International virtual ChromoendoScopy ScOre) in ulcerative colitis","volume":"86","author":"Iacucci","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1053\/j.gastro.2020.12.024","article-title":"An international multicenter real-life prospective study of electronic Chromoendoscopy score PICaSSO in ulcerative colitis","volume":"160","author":"Iacucci","year":"2021","journal-title":"Gastroenterology"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1177\/1756283X16649143","article-title":"Magnetic resonance enterography versus capsule endoscopy activity indices for quantification of small bowel inflammation in Crohn's disease","volume":"9","author":"Kopylov","year":"2016","journal-title":"Ther Adv Gastroenterol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1002\/ibd.21551","article-title":"Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity","volume":"17","author":"Rimola","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/apt.13024","article-title":"Systematic review with meta-analysis: magnetic resonance enterography signs for the detection of inflammation and intestinal damage in Crohn's disease","volume":"41","author":"Church","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1053\/j.gastro.2013.10.055","article-title":"Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease","volume":"146","author":"Ord\u00e1s","year":"2014","journal-title":"Gastroenterology"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/ajg.2013.385","article-title":"Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn's disease: validation of quantitative index of activity","volume":"109","author":"Hordonneau","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/RLU.0000000000001279","article-title":"False-positive finding on 18F FDG PET\/CT: report of a rare case with Xanthogranulomatous inflammation in the spinal epidural space","volume":"41","author":"Alam","year":"2016","journal-title":"Clin Nucl Med"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1136\/gutjnl-2015-309903","article-title":"IOIBD technical review on endoscopic indices for Crohn's disease clinical trials","volume":"65","author":"Vuitton","year":"2016","journal-title":"Gut"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1097\/MIB.0000000000001106","article-title":"Development of a novel predictive model for the clinical course of Crohn's disease: results from the CONNECT study","volume":"23","author":"Park","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"ref51","first-page":"859","article-title":"Serum neutrophil gelatinase-associated lipocalin (NGAL) correlates with clinical and endoscopic activity in ulcerative colitis but fails to predict activity in Crohn's disease","volume":"68","author":"Budzynska","year":"2017","journal-title":"J Physiol Pharmacol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/ecco-jcc\/jjz107","article-title":"Faecal calprotectin predicts endoscopic and histological activity in clinically quiescent ulcerative colitis","volume":"14","author":"Hart","year":"2020","journal-title":"J Crohns Colitis"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"346","DOI":"10.15403\/jgld-3818","article-title":"Risk factors for Extraintestinal manifestations in inflammatory bowel diseases\u2014data from the Romanian National Registry","volume":"30","author":"Singeap","year":"2021","journal-title":"J Gastrointes Liver Dis"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"i36","DOI":"10.1136\/gut.2005.081950c","article-title":"European evidence based consensus on the diagnosis and management of Crohn's disease: special situations","volume":"55","author":"Caprilli","year":"2006","journal-title":"Gut"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12881-017-0451-2","article-title":"Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method","volume":"18","author":"Chen","year":"2017","journal-title":"BMC Med Genet"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1093\/hmg\/ddg281","article-title":"The IBD6 Crohn's disease locus demonstrates complex interactions with CARD15 and IBD5 disease-associated variants","volume":"12","author":"van Heel","year":"2003","journal-title":"Hum Mol Genet"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.ajo.2006.01.075","article-title":"Family history of inflammatory bowel disease in patients with idiopathic ocular inflammation","volume":"141","author":"Lin","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1185\/030079907X210471","article-title":"Modeling the role of genetic factors in characterizing extra-intestinal manifestations in Crohn's disease patients: does this improve outcome predictions?","volume":"23","author":"Giachino","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"201","DOI":"10.7326\/0003-4819-144-3-200602070-00009","article-title":"Translating clinical research into clinical practice: impact of using prediction rules to make decisions","volume":"144","author":"Reilly","year":"2006","journal-title":"Ann Intern Med"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s11222-017-9767-1","article-title":"Bayesian additive regression trees using Bayesian model averaging","volume":"28","author":"Hern\u00e1ndez","year":"2018","journal-title":"Stat Comput"},{"key":"ref61","first-page":"884","article-title":"Bayesian machine learning techniques for revealing complex interactions among genetic and clinical factors in association with extra-intestinal manifestations in IBD patients","volume":"2016","author":"Menti","year":"2016","journal-title":"AMIA Annu Symp Proc"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060865","article-title":"The role of genetic factors in characterizing extra-intestinal manifestations in Crohn's disease patients: are Bayesian machine learning methods improving outcome predictions?","volume":"8","author":"Bottigliengo","year":"2019","journal-title":"J Clin Med"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1093\/ecco-jcc\/jjz043","article-title":"A validated score assessing the risk of an intra-abdominal abscess in patients with Crohn's disease presenting at the emergency department","volume":"13","author":"Khoury","year":"2019","journal-title":"J Crohns Colitis"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.21037\/apm-20-875","article-title":"Development and validation of predictive models for Crohn's disease patients with prothrombotic state: a 6-year clinical analysis","volume":"10","author":"Pan","year":"2021","journal-title":"Ann Palliat Med"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.3748\/wjg.v18.i31.4091","article-title":"Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?","volume":"18","author":"Andersen","year":"2012","journal-title":"World J Gastroenterol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.clcc.2011.03.011","article-title":"Predicting ulcerative colitis-associated colorectal cancer using reverse-transcription polymerase chain reaction analysis","volume":"10","author":"Watanabe","year":"2011","journal-title":"Clin Colorectal Cancer"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2174\/1574887117666220328125720","article-title":"The lesson from the first Italian lockdown: impacts on anxiety and depressive symptoms and sleep quality in patients with remission of inflammatory bowel disease","volume":"17","author":"Spina","year":"2022","journal-title":"Rev Recent Clin Trials"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"285","DOI":"10.5534\/wjmh.190007","article-title":"Sexual dysfunction and fertility problems in men with inflammatory bowel disease","volume":"38","author":"Park","year":"2020","journal-title":"World J Mens Health"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/ecco-jcc\/jjv140","article-title":"Inflammatory bowel disease and sexual function in male and female patients: an update on evidence in the past ten years","volume":"9","author":"Mantzouranis","year":"2015","journal-title":"J Crohns Colitis"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.dld.2022.07.016","article-title":"Therapeutic adherence recorded in the outpatient follow-up of inflammatory bowel diseases in a referral center: damages of COVID-19","volume":"54","author":"Pellegrino","year":"2022","journal-title":"Dig Liver Dis"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/01.PSY.0000106907.24881.F2","article-title":"Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study","volume":"66","author":"Mittermaier","year":"2004","journal-title":"Psychosom Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1186143\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T14:55:36Z","timestamp":1684335336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1186143\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,10]]},"references-count":71,"alternative-id":["10.3389\/fmed.2023.1186143"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1186143","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2023,5,10]]},"article-number":"1186143"}}